4d pharma (FRA:4DY) LT-Debt-to-Total-Asset : 0.23 (As of Dec. 2021)

View and export this data going back to 2020. Start your Free Trial

What is 4d pharma LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. 4d pharma's long-term debt to total assests ratio for the quarter that ended in Dec. 2021 was 0.23.

4d pharma's long-term debt to total assets ratio increased from Dec. 2020 (0.03) to Dec. 2021 (0.23). It may suggest that 4d pharma is progressively becoming more dependent on debt to grow their business.

4d pharma LT-Debt-to-Total-Asset Historical Data

The historical data trend for 4d pharma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma LT-Debt-to-Total-Asset Chart

4d pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.03

0.23

4d pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial											0.03	0.03	0.03	0.02	0.23

4d pharma LT-Debt-to-Total-Asset Calculation

4d pharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as

LT Debt to Total Assets (A: Dec. 2021 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2021 )	/	Total Assets (A: Dec. 2021 )
	=	11.592	/	50.534
	=	0.23

4d pharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2021 is calculated as

LT Debt to Total Assets (Q: Dec. 2021 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2021 )	/	Total Assets (Q: Dec. 2021 )
	=	11.592	/	50.534
	=	0.23

4d pharma (FRA:4DY) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

4d pharma LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of 4d pharma's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

4d pharma (FRA:4DY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (FRA:4DY) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ

Website

https://www.4dpharmaplc.com

4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

4d pharma (FRA:4DY) Headlines

No Headlines